文章摘要
熊梅,骆志成.合并甲状腺病变的嗜酸性筋膜炎 1例及文献复习[J].安徽医药,2023,27(5):1015-1017.
合并甲状腺病变的嗜酸性筋膜炎 1例及文献复习
Eosinophilic fasciitis with thyroid disease: a case report and literature review
  
DOI:10.3969/j.issn.1009-6469.2023.05.038
中文关键词: 嗜酸性筋膜炎  泼尼松  甲状腺病变  甲状腺乳头状癌  桥本甲状腺炎
英文关键词: Eosinophilic fasciitis  Prednisone  Thyroid disease  Papillary thyroid carcinoma  Hashimoto thyroiditis
基金项目:
作者单位E-mail
熊梅 兰州大学第二医院皮肤科甘肃兰州 730030  
骆志成 兰州大学第二医院皮肤科甘肃兰州 730030 luozhc@lzu.edu.cn 
摘要点击次数: 701
全文下载次数: 313
中文摘要:
      目的报告 1例合并甲状腺病变的嗜酸性筋膜炎( EF)病例,为今后临床诊治提供参考。方法兰州大学第二医院 2021年 4月 2日收治的 1例合并甲状腺疾病的女性 EF病例,对相关文献进行复习。结果女, 52岁。双肩关节皮肤肿痛 2月,双前臂皮肤肿胀、僵硬 1月,入院检查时发现甲状腺结节。双前臂“沟槽征”,双前臂核磁共振成像示筋膜炎症性改变,外周血嗜酸性粒细胞计数 0.55×109/L。甲状腺组织病理活检提示甲状腺乳头状癌、结节性甲状腺肿、桥本甲状腺炎。综上诊断为 EF、甲状腺恶性肿瘤(乳头状癌)、桥本甲状腺炎、结节性甲状腺肿。给予醋酸泼尼松片和甲氨蝶呤, 3月后皮损基本痊愈;并行双侧甲状腺切除 +左侧中央区清扫,随访 3月无复发及转移。结论 EF可能作为系统性疾病的皮肤表现,遇到此类病人除积极筛查自身免疫系统、血液系统相关疾病等常见合并症,也应该高度警惕实体肿瘤等少见合并症,早期识别各种潜在疾病。
英文摘要:
      Objective To report a case of eosinophilic fasciitis(EF)with thyroid disease, and to provide reference for clinical diagno-sis and treatment in the future.Methods A case of EF in a woman with thyroid disease admitted to tthe Second Hospital of LanzhouUniversity on April 2, 2021 was reported and the literature was reviewed.Results A 52-year-old female presented with skin swellingand pain on shoulder joints for 2 months, skin swelling and stiffness on forearms for 1 month. In addition, thyroid nodules were foundduring admission examination. Double forearm "groove sign"; magnetic resonance imaging of forearms showed inflammatory changes infascia; Eosinophil count was 0.55×109/L. A histopathologic biopsy of the thyroid suggested papillary thyroid carcinoma, nodular goiterand Hashimoto thyroiditis. In summary, the diagnosis of EF, thyroid malignant tumor (papillary carcinoma), Hashimoto thyroiditis andnodular goiter was made. The patient was treated with prednisone and methotrexate, and the lesions were basically cured 3 months lat-er. Bilateral thyroidectomy and left central area dissection were performed, and no recurrence and metastasis after 3-month follow-up. Conclusions EF may be a skin manifestation of systemic diseases. Patients with such manifestation should be actively screened forcommon complications such as autoimmune system and blood system related diseases, and should also be highly vigilant for rare com-plications such as solid tumors, so as to identify various potential diseases early.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮